| Bioequivalence study of a sustained release fixed dose combination capsule containing esomeprazole and domperidone in healthy subjects. | |
| | |
MedLine Citation:
|
PMID: 17598699 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The study was designed to determine the relative bioavailability of two sustained release fixed dose combination (FDC) products of two manufacturers containing esomeprazole (CAS 326602-80-6) 40 mg and domperidone (CAS 57808-66-9) 30 mg in 24 healthy male volunteers. The pharmacokinetics of esomeprazole and domperidone individually after oral administration of tablet formulation has been extensively evaluated in adult volunteers. However, no published data are available regarding the combined pharmacokinetics and bioavailability of this particular FDC. METHOD: The study was designed as a randomized, balanced, open-label, 2-period cross-over study. Each subject was randomized at the beginning of the study to receive either a single dose of the Test FDC or Reference FDC during Period I. Following a 7-day wash-out period, all subjects received the alternate formulation during Period II. RESULTS: No statistically significant differences were obtained between the two products with respect to the mean concentration-time profiles or in the pharmacokinetic parameters, including area under the serum concentration-time curve from the present study. The relative extent of absorption as assessed by the AUC ratio (Test/Reference) and C(max), the average value was found to be 1.00 +/- .09 with 90% confidence limits (C.L.) of 0.82-1.18. CONCLUSION: These findings clearly indicate that the two products are bioequivalent in terms of rate and extent of drug absorption. Both preparations were well tolerated with no adverse reactions throughout the study. |
| | |
Authors:
|
Sangita Agarwal; Kadajji Veeran Gowda; Uttam Mandal; Debotri Ghosh; Anirbandeep Bose; Amlan Kanti Sarkar; Tapas Kumar Chattaraj; Tapan Kumar Pal |
Related Documents
:
|
17786099 - Anti-inflammatory dose doxycycline (40 mg controlled-release) confers maximum anti-infl... 20428289 - A comparative review of oxybutynin chloride formulations: pharmacokinetics and therapeu... 20187859 - Cladribine tablets: a potential new short-course annual treatment for relapsing multipl... 2202549 - A comparison of two formulations of indomethacin ('flexin continus' tablets and 'indoci... 12193309 - Rectal administration of propylthiouracil in hyperthyroid patients: comparison of suspe... 15098799 - Influence of grapefruit juice on the systemic availability of itraconazole oral solutio... 12791539 - Inhibition of rat respiratory-tract cytochrome p-450 isozymes following inhalation of m... 22011689 - Thorough qt/qtc study of tocilizumab after single-dose administration at therapeutic an... 1738569 - Morphine blocks descending pain inhibitory controls in humans. |
Publication Detail:
|
Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Arzneimittel-Forschung Volume: 57 ISSN: 0004-4172 ISO Abbreviation: Arzneimittelforschung Publication Date: 2007 |
Date Detail:
|
Created Date: 2007-06-29 Completed Date: 2007-08-02 Revised Date: 2013-01-07 |
Medline Journal Info:
|
Nlm Unique ID: 0372660 Medline TA: Arzneimittelforschung Country: Germany |
Other Details:
|
Languages: eng Pagination: 274-7 Citation Subset: IM |
Affiliation:
|
Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700 032 West Bengal, India. Sangita_agarwal2000@yahoo.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anti-Ulcer Agents / administration & dosage, pharmacokinetics* Antiemetics / administration & dosage, pharmacokinetics* Biological Availability Capsules Chromatography, High Pressure Liquid Cross-Over Studies Delayed-Action Preparations Domperidone / administration & dosage, pharmacokinetics* Double-Blind Method Drug Combinations Esomeprazole Sodium / administration & dosage, pharmacokinetics* Female Half-Life Humans Male Spectrophotometry, Ultraviolet Therapeutic Equivalency |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Ulcer Agents; 0/Antiemetics; 0/Capsules; 0/Delayed-Action Preparations; 0/Drug Combinations; 57808-66-9/Domperidone; L2C9GWQ43H/Esomeprazole Sodium |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bioeqivalence assessment of two domperidone 1 tablet formulations.
Next Document: N'-[2-(2-thiophene) ethyl]-N'-[2-(5-bromopyridyl)]thiourea (HI-443), a rationally designed non-nucle...